Joseph Maroon - Mylan N Insider

MYL -- USA Stock  

USD 38.63  0.32  0.84%

Independent Director

Dr. Joseph C. Maroon, M.D., is an Independent Director of Mylan Inc., since 2003. Dr. Maroon is currently Professor, Heindl Scholar in Neuroscience and Vice Chairman of the Department of Neurosurgery, University of Pittsburgh Medical Center, and has held other positions at UPMC since 1998. He has also served as the team neurosurgeon for the Pittsburgh Steelers since 1981. From 1995 to 1998, Dr. Maroon was Professor and Chairman of the Department of Surgery at Allegheny General Hospital, and from 1984 to 1999 he was Professor and Chairman of the Department of Neurosurgery at Allegheny General Hospital. Dr. Maroon has earned numerous awards for his contributions to neurosurgery from various national and international neurological societies throughout his career, and patients travel from all over the world to seek his care.
Age: 73  Director Since 2003      
724-514-1800  http://www.mylan.com

Joseph Maroon Latest Insider Activity

Management Efficiency

The company has Return on Asset of 3.25 % which means that on every $100 spent on asset it made $3.25 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.77 % implying that it generated $5.77 on every 100 dollars invested.
The company has 15.07 B in debt with debt to equity (D/E) ratio of 114.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mylan N V has Current Ratio of 1.04 demonstrating that it may not be capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Robert MalchioneBio Rad Laboratories
2014
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Joseph ZaccagninoMallinckrodt Public Limited Com
2013
David CarlucciMallinckrodt Public Limited Com
2013
Roxanne AustinAbbott Laboratories
2000
Thomas GlocerMerck Co
2007
Martin CarrollMallinckrodt Public Limited Com
2013
Juan LucianoEli Lilly and Company
2016
William OsbornAbbott Laboratories
2013
Inge ThulinMerck Co
2018
Michael HyattEndo International plc
N/A
Daniel StarksAbbott Laboratories
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
David GreenwayVertex Pharmaceuticals Incorpor
2017
Douglas IngramEndo International plc
2016
Edward LiddyAbbott Laboratories
2010
Gregory HinckleyBio Rad Laboratories
2017
Karen HornEli Lilly and Company
2012
Togo WestBristol Myers Squibb Company
2015
William MontagueEndo International plc
2009
Angus RussellMallinckrodt Public Limited Com
2018

Entity Summary

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter products worldwide. Mylan N.V. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Mylan N operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 35000 people.Mylan N V (MYL) is traded on NASDAQ in USA. It is located in UNITED KINGDOM and employs 35,000 people. Mylan N is listed under Pharmaceutical Products category by Fama And French industry classification.

Mylan N V Leadership Team

Anthony Mauro, President
Joseph Maroon, Director
Kris King, VP
Heather Bresch, CEO
Melina Higgins, Director
Mark Parrish, Director
Kenneth Parks, CFO
Rodney Piatt, Chairman, CPA
Rajiv Malik, President
John Sheehan, President, CPA
Dennis Zeleny, Executive
JoEllen Dillon, Director
Neil Dimick, Director
Sjoerd Vollebregt, Director
Douglas Leech, Director
Robert Cindrich, Director
Wendy Cameron, Director
Rakesh Bamzai, President, MBA
Robert Coury, Chairman
Daniel Gallagher, Executive
Randall Vanderveen, Director

Stock Performance Indicators

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.